LifeMD, Inc. (LFMD) stock
LFMDNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMDP
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3025% below fair value
$1.66−0.13 (-7.02%)
Close on Nov 12, 2026Market cap $79.77MP/E –Yield –
LifeMD gross margin
Gross margin is gross profit as a percentage of revenue.
LifeMD's gross margin for the twelve months ending Sep 30, 2026 was 86.5%. For fiscal 2025 it was 85.7%, against 86.2% the year before. The highest annual figure on record is 87.6% in fiscal 2023.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 85.7% | −0.4 |
| FY2024 | Dec 31, 2024 | 86.2% | −1.5 |
| FY2023 | Dec 31, 2023 | 87.6% | +3.3 |
| FY2022 | Dec 31, 2022 | 84.3% | +3.7 |
| FY2021 | Dec 31, 2021 | 80.6% | +4.4 |
| FY2020 | Dec 31, 2020 | 76.2% | −3.5 |
| FY2019 | Dec 31, 2019 | 79.7% | +3.7 |
| FY2018 | Dec 31, 2018 | 76.0% | +3.7 |
| FY2017 | Dec 31, 2017 | 72.4% | +9.5 |
| FY2016 | Dec 31, 2016 | 62.9% | −16.8 |
| FY2015 | Dec 31, 2015 | 79.7% | +3.9 |
| FY2014 | Dec 31, 2014 | 75.8% | −1.8 |
| FY2013 | Dec 31, 2013 | 77.6% | +7.2 |
| FY2012 | Dec 31, 2012 | 70.3% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | 81.5% | −3.7 |
| Q2 FY2026 | Jun 30, 2026 | 88.8% | +2.8 |
| Q1 FY2026 | Mar 31, 2026 | 88.2% | +4.2 |
| Q4 FY2025 | Dec 31, 2025 | 87.1% | +111.1 |
| Q3 FY2025 | Sep 30, 2025 | 85.2% | −5.4 |
| Q2 FY2025 | Jun 30, 2025 | 86.0% | −4.0 |
| Q1 FY2025 | Mar 31, 2025 | 84.0% | −5.6 |
| Q4 FY2024 | Dec 31, 2024 | -24.0% | −112.0 |
| Q3 FY2024 | Sep 30, 2024 | 90.6% | +3.0 |
| Q2 FY2024 | Jun 30, 2024 | 90.1% | +2.7 |
| Q1 FY2024 | Mar 31, 2024 | 89.6% | +2.3 |
| Q4 FY2023 | Dec 31, 2023 | 88.1% | +2.5 |
| Q3 FY2023 | Sep 30, 2023 | 87.6% | +2.6 |
| Q2 FY2023 | Jun 30, 2023 | 87.3% | +2.6 |
| Q1 FY2023 | Mar 31, 2023 | 87.3% | +5.3 |
| Q4 FY2022 | Dec 31, 2022 | 85.5% | +5.8 |
| Q3 FY2022 | Sep 30, 2022 | 85.0% | +5.4 |
| Q2 FY2022 | Jun 30, 2022 | 84.8% | +3.2 |
| Q1 FY2022 | Mar 31, 2022 | 81.9% | −0.4 |
| Q4 FY2021 | Dec 31, 2021 | 79.7% | +10.2 |
| Q3 FY2021 | Sep 30, 2021 | 79.6% | −5.2 |
| Q2 FY2021 | Jun 30, 2021 | 81.5% | +0.2 |
| Q1 FY2021 | Mar 31, 2021 | 82.4% | +13.4 |
| Q4 FY2020 | Dec 31, 2020 | 69.5% | −17.6 |
| Q3 FY2020 | Sep 30, 2020 | 84.8% | +6.5 |
| Q2 FY2020 | Jun 30, 2020 | 81.4% | +5.6 |
| Q1 FY2020 | Mar 31, 2020 | 68.9% | −4.7 |
| Q4 FY2019 | Dec 31, 2019 | 87.0% | +17.5 |
| Q3 FY2019 | Sep 30, 2019 | 78.2% | −4.1 |
| Q2 FY2019 | Jun 30, 2019 | 75.7% | +2.0 |
| Q1 FY2019 | Mar 31, 2019 | 73.6% | −4.3 |
| Q4 FY2018 | Dec 31, 2018 | 69.5% | −81.7 |
| Q3 FY2018 | Sep 30, 2018 | 82.4% | +8.5 |
| Q2 FY2018 | Jun 30, 2018 | 73.8% | +1.8 |
| Q1 FY2018 | Mar 31, 2018 | 77.9% | +30.4 |
| Q4 FY2017 | Dec 31, 2017 | 151.2% | +120.0 |
| Q3 FY2017 | Sep 30, 2017 | 73.9% | – |
| Q2 FY2017 | Jun 30, 2017 | 72.0% | – |
| Q1 FY2017 | Mar 31, 2017 | 47.5% | – |
| Q4 FY2016 | Dec 31, 2016 | 31.3% | – |
See a number that looks wrong?